Childhood cancers: open trials in Taiwan

30 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Chung Shan Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-11-06
NCT05862285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Trial Treatment · Phase 3 · Hoffmann-La Roche
Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Chang Gung Memorial Hospital, Linkou, Taoyuan
Registry updated 2026-11-06
NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
China Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-11-04
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
National Taiwan University Hospital (Site 1983), Taipei
Registry updated 2026-10-30
NCT07700758
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
National Taiwan University Hospital (Site 5983), Taipei
Registry updated 2026-10-30
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · AstraZeneca
Taichung · Taipei
Registry updated 2026-10-15
NCT07387926
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Taipei
Registry updated 2026-10-15
NCT04566380
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Trial Treatment · Phase 2 · Ono Pharmaceutical Co., Ltd.
Kaohsiung City · Kaohsiung City · New Taipei City · Tainan · Tainan · Taipei · Taipei · Taoyuan
Registry updated 2026-10-14
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-10-13
NCT05377307
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Research · Pell Bio-Med Technology Co., Ltd.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung · Chi Mei Medical Center, Tainan · Taipei Medical University - Taipei Medical University Hospital, Taipei · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-10-09
NCT06941272
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
National Taiwan University Hospital (Site 3983), Taiwan
Registry updated 2026-10-06
NCT07688252
Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma
Trial Treatment · Phase 1 · Chang Gung Memorial Hospital
National Taiwan University Hospital, Taipei · Chang Gung Memorial Hospital, Linkou Branch, Taoyuan
Registry updated 2026-10-06
NCT07306832
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 1 · AbbVie
National Taiwan University Hospital /ID# 276635, Taipei
Registry updated 2026-10-05
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Changhua · Kaohsiung City · New Taipei City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-09-30
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Taipei Medical University Hospital, Taipei · Taipei
Registry updated 2026-09-25
NCT05118789
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Chung Shan Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-09-24
NCT07805096
Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health
Trial Treatment · National Defense Medical University, Taiwan
National Taiwan University Children's Hospital, Taipei
Registry updated 2026-09-04
NCT07730164
One-Page Truth-Telling Aid for Cancer Disclosure
Trial Treatment · Chang Gung University
Chang Gung University, Taoyuan
Registry updated 2026-07-28
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Taoyuan
Registry updated 2026-07-06
NCT06985576
Long-term Study to Evaluate Safety and Persistence of GF-CART01
Research · GenomeFrontier Therapeutics TW Co., Ltd.
National Taiwan University Hospital, Taipei
Registry updated 2026-06-11
NCT05430971
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Research · Immune Oncology Research Institute
China Medical University Children's Hospital, Taichung
Registry updated 2026-06-05
NCT03093116
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Taiepi · Tainan · Taipei
Registry updated 2026-05-27
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-03-24
NCT07385976
The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
Research · Far Eastern Memorial Hospital
Far Eastern Memorial Hospital, New Taipei City · Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital,, New Taipei City
Registry updated 2026-02-04
NCT07296250
Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT
Trial Treatment · Chang Gung Memorial Hospital
Linkou Chang-Gung Memorial Hospital, Taoyuan City
Registry updated 2025-12-22

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error